Adaptive Biotech

@AdaptiveBiotech

Adaptive Biotechnologies is a pioneer & leader in immune-driven medicine. We aim to improve lives by learning from the wisdom of our adaptive immune systems.

Seattle, WA. U.S.A.
Vrijeme pridruživanja: travanj 2012.

Tweetovi

Blokirali ste korisnika/cu @AdaptiveBiotech

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AdaptiveBiotech

  1. Today and every day, we are honored to work together toward such an important goal to transform the diagnosis and treatment of cancer.

    Poništi
  2. 31. sij

    Our Sr Dir Corp Comms moderated first event of the year – the 2nd Annual Insights & Trends from – to discuss partnering, investment, and key issues facing women in the industry in 2020. Proud to be a partner of Region.

    Poništi
  3. 29. sij

    Check out blog on Adaptive's test: is FDA-cleared to assess MRD in B-ALL & MM patients’ bone marrow; not FDA-cleared in CLL but available as LDT from our CLIA lab. For impt info + test limitations:

    Poništi
  4. 23. sij

    Join Director of Immunomics Jonathan Carlson, Ph.D. for an update on the TCR-Antigen Map today, Thursday 1/23 at 11AM PT at Track 2: More info:

    Poništi
  5. 23. sij

    Be sure to join Pam Bradley, Director of Policy and Advocacy for an informative panel discussion on the rapidly evolving regulatory and reimbursement landscape in clinical diagnostics at today, Thurs. 1/23 at 11:15AM PT at Track 4. Info:

    Poništi
  6. 22. sij

    Don't miss Chief Medical Officer Lance Baldo's presentation on how immune-driven medicine could transform the diagnosis and treatment of disease at this Thursday, Jan. 23 at 9:00AM PT at Track 1. Learn more about Lance:

    Poništi
  7. 22. sij

    “We are going after multiple TCRs against multiple targets simultaneously...that’s why we’re excited about this strategy” - CSO Harlan Robins, with VP, Cancer Immunology, Ira Mellman at Learn more about our partnership:

    Poništi
  8. proslijedio/la je Tweet
    21. sij

    Tomorrow at , Ira Mellman, Vice President, Cancer Immunology, joins Co-founder & Chief Scientific Officer, Harlan Robins, for a fireside chat on cancer immunotherapy. Read more about our partnership with Adaptive.

    Poništi
  9. 21. sij

    Join co-founder & Chief Scientific Officer, Harlan Robins, and Vice President, Cancer Immunology, Ira Mellman at for a fireside chat on progress, challenges, and what’s next for cancer immunotherapy. Read more about our partnership:

    Poništi
  10. 20. sij

    As published in , uses the immunoSEQ Assay to make quantitative, accurate predictions about which primary melanomas are likely to recur and spread. Read the full press release here: RUO. Not for use in diagnostic procedures.

    Poništi
  11. 16. sij

    “Immunomics has the potential to help clinicians and researchers to better understand the relationship between diseases and our bodies natural ability to diagnose and treat them.” Read CEO Chad Robins’ article on the future use of :

    Poništi
  12. 15. sij

    The immunome is orders of magnitude larger than the human genome. While it’s difficult to accurately decipher this massive genetic code, it’s what Adaptive has set out to do. Listen to CEO Chad Robins’ full presentation here:

    Poništi
  13. 14. sij

    Join us today from at 1:30PM PT as CEO and Co-founder Chad Robins discusses how Adaptive aims to transform and personalize disease diagnosis and treatment by translating the genetic code of each patient’s unique immune system. Webcast:

    Poništi
  14. proslijedio/la je Tweet
    14. sij

    Scientific innovation and strong partners go hand-in-hand. Read more about our work with and to harness the power of our immune systems against cancer.

    Poništi
  15. 14. sij

    Join CEO Chad Robins live from on Tuesday, January 14 at 1:30PM PT as he discusses how Adaptive aims to translate the genetics of the adaptive immune system to transform the diagnosis and treatment of disease. Access the webcast:

    Poništi
  16. 13. sij

    TUNE IN: The Secrets Behind Built-To-Last Companies discussion with Adaptive CEO Chad Robins, and Konstantinos Alataris at the Health Innovator Summit today at 2:15PM PT. Live stream:

    Poništi
  17. 13. sij

    What is the secret behind healthcare companies built to last? Our CEO Chad Robins will discuss his journey at the Health Innovator Summit Monday, January 13, 2020 2:15-3:30PM PT. Tune in to the live stream:

    Poništi
  18. 23. pro 2019.

    Wishing you a very happy holiday season from all of us here at

    Poništi
  19. 23. pro 2019.

    Thank you . We are also excited to be a Gold Level Corporate Partner and part of the HBA community!

    Poništi
  20. 23. pro 2019.

    Discover the power and versatility of the new immunoSEQ Kit. Available now! Learn more here: Research Use Only. Not for use in diagnostic procedures.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·